Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

The paper presents a detailed algorithm for the treatment and follow-up of patients with recurrent multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab.

Saved in:
Bibliographic Details
Published inNevrologii͡a︡, neĭropsikhiatrii͡a︡, psikhosomatika Vol. 11; no. 3; pp. 16 - 25
Main Authors Boyko, A. N., Davydovskaya, M. V., Khachanova, N. V., Zakharova, M. N., Spirin, N. N., Popova, E. V., Alifirova, V. M., Vlasov, Ya. V., Sivertseva, S. A., Khabirov, F. A., Shumilina, M. V., Evdoshenko, E. P.
Format Journal Article
LanguageEnglish
Published IMA-PRESS LLC 01.11.2019
Subjects
monoclonal antibody
multiple sclerosis
ocrelizumab
primary progressive multiple sclerosis
recurrent multiple sclerosis
Online AccessGet full text

Cover

More Information
Summary:The paper presents a detailed algorithm for the treatment and follow-up of patients with recurrent multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab.
ISSN:2074-2711
2310-1342
DOI:10.14412/2074-2711-2019-3-16-25